TTK Healthcare Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.
TTKHLTCARE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
TTK Healthcare reported FY2025-26 revenue of Rs. 85,728 lakhs, up 7% from Rs. 80,149 lakhs in FY2024-25. However, Profit After Tax declined 19.6% to Rs. 6,568 lakhs from Rs. 8,166 lakhs in the previous year. The PAT decline was primarily due to a net exceptional charge of Rs. 407 lakhs, which included Rs. 758 lakhs for compliance with new Labour Codes (Gratuity and Compensated Absences), partially offset by Rs. 350 lakhs GST refund. EPS fell to Rs. 46.48 from Rs. 57.79. The Board recommended a dividend of Rs. 10 per share (100%). Statutory auditors issued an unmodified (clean) opinion. The company also reappointed Mr. T T Raghunathan as Executive Chairman for 5 years and appointed Geeyes & Co. as Cost Auditors.
PAT declined significantly year-on-year due to one-time labour code compliance costs, but the company remains profitable and continues dividend payouts. The clean audit opinion provides assurance on financial reporting quality. The stock may see muted reaction given the PAT decline despite stable revenue growth.